Developing small molecules to discover and manipulate protein targets
Probes, Inhibitors, and PROTACs (PIP) Core
This study is working on new tiny molecules that can help scientists find and control certain proteins in our bodies, which could lead to better treatments for diseases caused by protein problems.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Nebraska Medical Center NIH-funded |
| Lab location | 1 site (Omaha, United States) |
| Project ID | NIH-10891534 on NIH RePORTER |
What this research studies
This research focuses on creating small molecules that can help identify and manipulate specific proteins involved in various biological processes. By using advanced chemistry and mass spectrometry techniques, the project aims to develop tools that can either enhance or inhibit the function of these proteins. This approach allows for precise control over protein activity, which is crucial for understanding their roles in diseases and for developing new therapeutic strategies. Patients may benefit from the insights gained through this research, as it could lead to more effective treatments for conditions related to protein dysfunction.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions related to protein misregulation or dysfunction.
Not a fit: Patients with conditions unrelated to protein function or those who do not have a specific protein target identified may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that more effectively target diseases linked to protein dysfunction.
How similar studies have performed: Other research has shown promise in using small molecules for protein modulation, indicating that this approach has potential for success.
Where this research is happening
Omaha, United States
- University of Nebraska Medical Center — Omaha, United States (Active)
Researchers
- Principal investigator: Natarajan, Amarnath (Amar) — University of Nebraska Medical Center
- Study coordinator: Natarajan, Amarnath (Amar)
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.